Science Magazine | AAAS: Science Translational Medicine Follow Mutant p53 reactivation and DNA demethylation in the treatment of AML/MDS | Science Translational Medicine Mutant p53 reactivation combined with DNA demethylation kills AML/MDS cells, showing efficacy in a pilot clinical trial. https://www.science.org/doi/10.1126/scitranslmed.ads9325 science.org
